Catalyst Wire Dossier Catalyst Wire Dossier

Nebivolol 0.5 suspension

nebivolol · Betaliq, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nebivolol 0.5 suspension, covering 2024-04-17 to 2024-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension [Phase 2]

See pricing